CIK 0001398733 · Non-accelerated filer<br>Smaller reporting company
Aquestive Therapeutics, Inc.
Sign in to watch- Ticker
- AQST
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208623253
- Phone
- 908-941-1900
- Business address
- 184 LIBERTY CORNER ROAD, SUITE 305, WARREN, NJ
- Former names
- MonoSol Rx, Inc.
- Open-market buys, last 90 days
- $99,331
- in 1 filing
- Open-market sales, last 90 days
- $378,930
- in 4 filings, $379K under 10b5-1 plans
Net −$279,599. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-29 | Schobel Alexander Mark Chief Innovation/Tech Officer | Option exercise · Restricted Stock Units | −14,572 | 14,572 | ||
| 2020-02-29 | Kendall Keith J CEO and President | Option exercise | +14,572 | 685,383 | ||
| 2020-02-29 | Kendall Keith J CEO and President | Shares withheld for taxes | −4,729 | $3.73 | $18K | 680,654 |
| 2020-02-29 | Kendall Keith J CEO and President | Option exercise · Restricted Stock Units | −14,572 | 14,572 | ||
| 2019-12-31 | Kendall Keith J CEO and President | Shares withheld for taxes | −149 | $5.82 | $867 | 670,811 |
| 2019-12-31 | Schobel Alexander Mark Chief Innovation/Tech Officer | Shares withheld for taxes | −147 | $5.82 | $856 | 1,052,375 |
| 2019-12-31 | Schobel Alexander Mark Chief Innovation/Tech Officer | Option exercise | +329 | 1,044,494 | ||
| 2019-12-31 | Schobel Alexander Mark Chief Innovation/Tech Officer | Shares withheld for taxes | −329 | $5.82 | $2K | 1,044,165 |
| 2019-12-31 | Schobel Alexander Mark Chief Innovation/Tech Officer | Option exercise · Restricted Stock Units | −329 | 662 | ||
| 2019-12-31 | Kendall Keith J CEO and President | Option exercise | +329 | 662,985 | ||
| 2019-12-31 | Kendall Keith J CEO and President | Shares withheld for taxes | −329 | $5.82 | $2K | 662,656 |
| 2019-12-31 | Kendall Keith J CEO and President | Option exercise · Restricted Stock Units | −329 | 662 | ||
| 2019-11-30 | Kendall Keith J CEO and President | Shares withheld for taxes | −6,597 | $7.79 | $51K | 670,631 |
| 2019-11-30 | Schobel Alexander Mark Chief Innovation/Tech Officer | Shares withheld for taxes | −6,544 | $7.79 | $51K | 1,052,193 |
| 2019-11-30 | Kendall Keith J CEO and President | Option exercise | +14,572 | 677,228 | ||
| 2019-11-30 | Kendall Keith J CEO and President | Shares withheld for taxes | −14,572 | $7.79 | $114K | 662,656 |
| 2019-11-30 | Kendall Keith J CEO and President | Option exercise · Restricted Stock Units | −14,572 | 29,144 | ||
| 2019-11-30 | Schobel Alexander Mark Chief Innovation/Tech Officer | Option exercise | +14,572 | 1,058,737 | ||
| 2019-11-30 | Schobel Alexander Mark Chief Innovation/Tech Officer | Shares withheld for taxes | −14,572 | $7.79 | $114K | 1,044,165 |
| 2019-11-30 | Schobel Alexander Mark Chief Innovation/Tech Officer | Option exercise · Restricted Stock Units | −14,572 | 29,144 |
Page 17 of 24 · 462 trades